U.S. flag

An official website of the United States government

NM_022132.5(MCCC2):c.838G>T (p.Asp280Tyr) AND 3-methylcrotonyl-CoA carboxylase 2 deficiency

Germline classification:
Pathogenic/Likely pathogenic (5 submissions)
Last evaluated:
Apr 9, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002004.18

Allele description [Variation Report for NM_022132.5(MCCC2):c.838G>T (p.Asp280Tyr)]

NM_022132.5(MCCC2):c.838G>T (p.Asp280Tyr)

Gene:
MCCC2:methylcrotonyl-CoA carboxylase subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q13.2
Genomic location:
Preferred name:
NM_022132.5(MCCC2):c.838G>T (p.Asp280Tyr)
HGVS:
  • NC_000005.10:g.71634977G>T
  • NG_008882.1:g.52690G>T
  • NM_001363147.1:c.724G>T
  • NM_022132.5:c.838G>TMANE SELECT
  • NP_001350076.1:p.Asp242Tyr
  • NP_071415.1:p.Asp280Tyr
  • NC_000005.9:g.70930804G>T
  • NM_022132.4:c.838G>T
  • Q9HCC0:p.Asp280Tyr
Protein change:
D242Y; ASP280TYR
Links:
UniProtKB: Q9HCC0#VAR_067199; OMIM: 609014.0009; dbSNP: rs119103226
NCBI 1000 Genomes Browser:
rs119103226
Molecular consequence:
  • NM_001363147.1:c.724G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022132.5:c.838G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
3-methylcrotonyl-CoA carboxylase 2 deficiency
Synonyms:
METHYLCROTONYLGLYCINURIA, TYPE II; 3 alpha methylcrotonyl-CoA carboxylase 2 deficiency; 3 alpha methylcrotonylglycinuria 2; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008862; MedGen: C1859499; Orphanet: 6; OMIM: 210210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022162OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000955887Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 6, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV001622419Genetics and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 13, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004194350Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 29, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005666607Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 9, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Uneventful clinical courses of Korean patients with methylcrotonylglycinuria and their common mutations.

Jung CW, Lee BH, Kim JH, Kim GH, Lee J, Choi JH, Yoo HW.

J Hum Genet. 2012 Jan;57(1):62-4. doi: 10.1038/jhg.2011.116. Epub 2011 Oct 27.

PubMed [citation]
PMID:
22030835

Mutational spectrum in eight Korean patients with 3-methylcrotonyl-CoA carboxylase deficiency.

Cho SY, Park HD, Lee YW, Ki CS, Lee SY, Sohn YB, Park SW, Kim SH, Ji S, Kim SJ, Choi EW, Kim CH, Ko AR, Paik KH, Lee DH, Jin DK.

Clin Genet. 2012 Jan;81(1):96-8. doi: 10.1111/j.1399-0004.2011.01704.x. No abstract available.

PubMed [citation]
PMID:
22150417
See all PubMed Citations (6)

Details of each submission

From OMIM, SCV000022162.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

For discussion of the asp280-to-tyr (D280Y) mutation in the MCCC2 gene that was found in compound heterozygous state in a patient with MCC2 deficiency (MCC2D; 210210) by Uematsu et al. (2007), see 609014.0008.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000955887.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 280 of the MCCC2 protein (p.Asp280Tyr). This variant is present in population databases (rs119103226, gnomAD 0.09%). This missense change has been observed in individuals with 3 methylcrotonyl-CoA carboxylase deficiency (PMID: 17968484, 22030835, 22150417, 28018443). ClinVar contains an entry for this variant (Variation ID: 1927). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MCCC2 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genetics and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, SCV001622419.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004194350.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV005666607.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025